Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistEntia Biosciences, Inc. was cited for marketing six mushroom-based dietary supplement products (Lion's Mane, Antrodia, Maitake, Reishi, and Cordyceps) as unapproved drugs through their website www.totalnutraceutical.com. The products violated the Federal Food, Drug, and Cosmetic Act because their marketing claims—including statements that they help lower cholesterol, reduce inflammation, treat liver disease and hypertension, and promote balanced blood sugar—established them as drugs intended to cure, mitigate, treat, or prevent disease rather than as dietary supplements. The FDA identified these violations during website reviews conducted in September and December 2020.